Adenocarcinoma of the prostate is the most common cancer of adult males in the United States. Of the patients diagnosed with this malignancy each year, over one half have locally advanced or metastatic disease at the time of diagnosis.While it is generally accepted that the growth and differentiation of benign and malignant prostatic epithelium is regulated by androgens, epidemiologic evidence suggests that 1alpha-25(OH)2 vitamin D3 [1alpha, 25(OH)2D3] may also play a role in prostatic carcinoma progression. The investigators have recently discovered that in addition to androgen receptors, human prostatic carcinoma cells also contain specific, high affinity receptors for 1,25(OH)2D3. The preliminary studies by the investigators using LNCaP cells have revealed that 1,25(OH)2D3 is capable of regulating growth (cell number), and prostate specific antigen production in a dose dependent fashion. The proposal outlines the rationale and methods to further test the hypothesis that receptors for vitamin D metabolites can modulate the growth and/or differentiation of human prostatic carcinoma cells in vitro and/or in vivo. A variety of human prostatic carcinoma cell lines including LNCaP, PC-3, DU 145, ALVA 31, PPC-1, TSU-PR1 and JCA-1 will be examined. Vitamin D receptors in these cells will be characterized by competitive binding, sucrose gradient sedimentation, DNA affinity chromatography and Western blot analysis. Metabolism of 1,25(OH)2D3 in vitro will be assessed using high pressure liquid chromatography and/or gas chromatography/mass spectrometry. Regulation of vitamin D, androgen and epidermal growth factor receptor expression will be assessed using competitive binding and/or Northern blots. Phenotypic differentiation will be assayed using radioimmunometric assays of prostate- specific antigen (PSA) and/or prostate specific acid phosphatase. Analysis of PSA mRNA synthesis will be assessed by Northern and slot blot assay. The results obtained with continuous carcinoma cell lines will be compared to those obtained with primary cultures of benign and/or malignant prostatic epithelial cells. Finally, the effects of vitamin D deficiency or excess will be evaluated in vivo using xenografts to nude mice or nude rats.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA053520-03
Application #
2095372
Study Section
Pathology A Study Section (PTHA)
Project Start
1992-08-18
Project End
1996-07-31
Budget Start
1994-08-01
Budget End
1996-07-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Pathology
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
van Bokhoven, A; Varella-Garcia, M; Korch, C et al. (2001) Widely used prostate carcinoma cell lines share common origins. Prostate 47:36-51
Nesterov, A; Lu, X; Johnson, M et al. (2001) Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J Biol Chem 276:10767-74
Moffatt, K A; Johannes, W U; Hedlund, T E et al. (2001) Growth inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31. Cancer Res 61:7122-9
Miller, G J; Torkko, K C (2001) Natural history of prostate cancer--epidemiologic considerations. Epidemiol Rev 23:14-8
Varella-Garcia, M; Boomer, T; Miller, G J (2001) Karyotypic similarity identified by multiplex-FISH relates four prostate adenocarcinoma cell lines: PC-3, PPC-1, ALVA-31, and ALVA-41. Genes Chromosomes Cancer 31:303-15
van Bokhoven, A; Varella-Garcia, M; Korch, C et al. (2001) TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. Cancer Res 61:6340-4
Hedlund, T E; Duke, R C; Miller, G J (1999) Three-dimensional spheroid cultures of human prostate cancer cell lines. Prostate 41:154-65
Moffatt, K A; Johannes, W U; Miller, G J (1999) 1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines. Clin Cancer Res 5:695-703
Miller, G J (1998) Vitamin D and prostate cancer: biologic interactions and clinical potentials. Cancer Metastasis Rev 17:353-60
Hedlund, T E; Duke, R C; Schleicher, M S et al. (1998) Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage. Prostate 36:92-101

Showing the most recent 10 out of 15 publications